Neglected Tropical Diseases

Neglected Tropical Diseases
Name	Neglected Tropical Diseases
Field	Tropical medicine

Neglected Tropical Diseases are a heterogeneous group of infectious conditions that disproportionately affect populations in low-income regions and are historically under-resourced by global health systems. They overlap with environments and institutions involved in tropical medicine, international development, and humanitarian response, and they intersect with efforts by organizations, treaties, and campaigns aimed at reducing global health inequities. Major initiatives by agencies and foundations have sought integrated approaches spanning clinical care, vector control, and community-based interventions.

Overview

These conditions have been the subject of programs by World Health Organization, United Nations, Bill & Melinda Gates Foundation, Centers for Disease Control and Prevention, and regional bodies such as African Union and European Commission while also engaging non-governmental organizations like Médecins Sans Frontières, The Carter Center, and Rotary International. Historical efforts trace through milestones such as the Alma-Ata Declaration and the Millennium Development Goals to contemporary frameworks including the Sustainable Development Goals. Responses occur across platforms ranging from academic centers such as Liverpool School of Tropical Medicine and London School of Hygiene & Tropical Medicine to research institutes like Institut Pasteur and Kofi Annan Foundation.

Causes and Pathogens

Etiologic agents include parasites, bacteria, viruses, and fungi associated with specific vectors and reservoirs studied by specialists at institutions including Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, and Oswaldo Cruz Foundation. Representative pathogens include helminths (e.g., species targeted by programs at PATH), protozoa investigated in collaborations with Wellcome Trust and National Institutes of Health, bacteria central to campaigns by World Health Organization and The Carter Center, and arboviruses monitored by Pan American Health Organization. Vector species studied in entomology collections at Natural History Museum, London and Smithsonian Institution include mosquitoes, sandflies, and tsetse flies implicated in transmission cycles analyzed in field sites in Brazil, India, Kenya, Nigeria, and Bangladesh.

Epidemiology and Global Burden

Burden estimates appear in reports by World Health Organization, analyses by Institute for Health Metrics and Evaluation, and policy briefs from United Nations Development Programme. Endemic foci often align with regions included in programs supported by Global Fund to Fight AIDS, Tuberculosis and Malaria, USAID, and bilateral initiatives from Department for International Development and Japan International Cooperation Agency. Surveillance networks link ministries of health in countries such as Ethiopia, Mozambique, Philippines, Haiti, and Venezuela with laboratories like KEMRI and National Institute of Allergy and Infectious Diseases. Economic and social impacts have been highlighted in commissions led by figures like Paul Farmer and reports involving World Bank and Oxfam.

Clinical Manifestations and Diagnosis

Clinical syndromes range from dermatologic lesions addressed by clinics modeled on Dermatology Centre programs to neurologic presentations investigated at centers like Mayo Clinic and Sheffield Teaching Hospitals. Diagnostic platforms include point-of-care tests produced in partnerships with Cepheid and laboratory assays developed at European Centre for Disease Prevention and Control and Institut Pasteur. Training and capacity-building occur via collaborations with medical schools such as University of Cambridge, University of Oxford, and Makerere University. Case definitions and clinical guidelines have been promulgated by bodies including World Health Organization expert committees and professional societies like Infectious Diseases Society of America.

Treatment and Control Strategies

Mass drug administration campaigns have been implemented with logistical support from The Carter Center, Rotary International, and national programs coordinated by ministries in India, China, and Uganda. Antiparasitic agents and antibiotics used in programs originate from research funded by Wellcome Trust, European Union Horizon 2020, and pharmaceutical donors including GlaxoSmithKline and Pfizer. Vector control strategies employ insecticides evaluated by Centers for Disease Control and Prevention and innovations tested in trials endorsed by London School of Hygiene & Tropical Medicine and University of California, Berkeley. Integrated strategies draw on lessons from eradication campaigns such as the Smallpox eradication and Guinea worm eradication efforts.

Prevention and Public Health Interventions

Preventive measures include water, sanitation, and hygiene projects coordinated with UNICEF and infrastructure investments financed by World Bank and regional development banks like the African Development Bank. Health education campaigns have partnered with media outlets and celebrities endorsed in initiatives by UNAIDS and advocacy by Amnesty International. Immunization and vaccine research efforts are occurring in consortia involving Gavi, the Vaccine Alliance, National Institutes of Health, and biotech firms collaborating with European Medicines Agency for regulatory pathways. Community-directed interventions have drawn on models from Primary Health Care movement and pilot programs supported by Bill & Melinda Gates Foundation.

Research, Policy, and Funding Challenges

Research priorities are coordinated by consortia such as Coalition for Epidemic Preparedness Innovations and influenced by funders including Wellcome Trust and Bill & Melinda Gates Foundation. Policy debates feature stakeholders like World Health Organization, United Nations, World Bank, and advocacy groups including Partners In Health. Funding constraints intersect with intellectual property discussions in venues like World Trade Organization and clinical trial governance overseen by Food and Drug Administration and European Medicines Agency. Capacity strengthening initiatives involve partnerships with universities such as Yale School of Public Health and Columbia University and implementation science networks linked to National Institutes of Health and Wellcome Trust.

Category:Tropical diseases